On May 29, 2013 J. Christopher Mizer was dismissed from his position as president of Bio-Matrix Scientific Group Inc.'s wholly owned subsidiary, Regen BioPharma Inc. The position of president of Regen BioPharma Inc. has been assumed by David R. Koos, Bio-Matrix Scientific Group Inc.'s Chairman and Chief Executive Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -.--% | -4.76% | +5.26% |
1st Jan change | Capi. | |
---|---|---|
+5.26% | 4.17M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RGBP Stock
- News Regen BioPharma, Inc.
- Regen BioPharma Inc. Announces Change of President